Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.80 -0.14 (-2.09%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Other Non-Current Assets (2020 - 2026)

Ginkgo Bioworks Holdings' (DNA) quarterly Other Non-Current Assets came in at $87.5 million in Q2 2026, up 83.07% on a YoY basis from $47.8 million in Q2 2025, and up 121.35% quarter-over-quarter from $39.5 million in Q1 2026.

Analysis

Ginkgo Bioworks Holdings (DNA) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Ginkgo Bioworks Holdings (DNA) has reported Other Non-Current Assets for 7 consecutive years, with $87.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Non-Current Assets rose 83.07% year-over-year to $87.5 million; the trailing twelve-month figure through Jun 2026 stood at $87.5 million (up 83.07% YoY), and the FY2025 full-year result was $45.2 million, up 2.26% from the prior year.
  • Other Non-Current Assets advanced to $87.5 million in Q2 2026 per DNA's latest filing, from $39.5 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $97.9 million in Q2 2023 and bottomed at $39.5 million in Q1 2026.
  • Historically, Other Non-Current Assets has averaged $62.4 million across 5 years, with a median of $55.5 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets jumped 120.87% in 2023, then tumbled 38.53% in 2024.
  • Over 5 years, Other Non-Current Assets stood at $88.7 million in 2022, then tumbled by 34.57% to $58.1 million in 2023, then fell by 23.92% to $44.2 million in 2024, then advanced by 2.26% to $45.2 million in 2025, then surged by 93.67% to $87.5 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $87.5 million, $39.5 million, and $45.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn 558.00 Mn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 25.20 Mn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn 587.56 Mn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn 117.41 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn 91.80 Mn
6 Evotec SE 661.34 Mn 235.46 Mn - 1.28 Mn
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn 87.48 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn 212,000.00
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn 91,917.76
10 VivoSim Labs 1.47 Mn 1.47 Mn - 143,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 87.48 Mn
Mar 31, 2026 39.52 Mn
Dec 31, 2025 45.17 Mn
Sep 30, 2025 46.59 Mn
Jun 30, 2025 47.79 Mn
Mar 31, 2025 46.78 Mn
Dec 31, 2024 44.17 Mn
Sep 30, 2024 59.79 Mn
Jun 30, 2024 60.21 Mn
Mar 31, 2024 60.63 Mn
Dec 31, 2023 58.06 Mn
Sep 30, 2023 97.02 Mn
Jun 30, 2023 97.95 Mn
Mar 31, 2023 97.26 Mn
Dec 31, 2022 88.73 Mn
Sep 30, 2022 43.93 Mn
Jun 30, 2022 53.02 Mn
Mar 31, 2022 49.62 Mn
Dec 31, 2021 43.99 Mn
Sep 30, 2021 26.80 Mn